We are live on ! Find out more
OA

Oxbow Advisors Portfolio holdings

AUM $1.18B
1-Year Est. Return 28.15%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+28.15%
3 Year Est. Return
+72.79%
5 Year Est. Return
+88.47%
10 Year Est. Return
+169.66%
AUM
$830M
AUM Growth
+$8.25M
Cap. Flow
-$8.34M
Cap. Flow %
-1%
Top 10 Hldgs %
33.39%
Holding
316
New
20
Increased
108
Reduced
85
Closed
10

Sector Composition

Rank Sector Weight
1 Energy 14.88%
2 Financials 7.27%
3 Technology 5.97%
4 Communication Services 4.08%
5 Consumer Discretionary 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLOP.PRA
101
GasLog Partners LP 8.625% Series A Preference Units
GLOP.PRA
$1.79M 0.22%
73,495
+600
+0.8% +$14.7K
WFC icon
102
Wells Fargo
WFC
$261B
$1.77M 0.21%
37,332
+2,787
+8% +$130K
UTF icon
103
Cohen & Steers Infrastructure Fund
UTF
$3.14B
$1.76M 0.21%
67,756
+3,400
+5% +$84.4K
HCA icon
104
HCA Healthcare
HCA
$84.8B
$1.75M 0.21%
12,933
-1,245
-9% -$157K
RNP icon
105
Cohen & Steers REIT and Preferred and Income Fund
RNP
$991M
$1.7M 0.2%
78,590
-1,394
-2% -$29.2K
ABFL
106
Abacus FCF Leaders ETF
ABFL
$527M
$1.67M 0.2%
44,776
-973
-2% -$35.4K
FBT icon
107
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
$1.66M 0.2%
11,770
+2,200
+23% +$304K
VZ icon
108
Verizon
VZ
$194B
$1.62M 0.2%
28,364
+954
+3% +$55K
WH icon
109
Wyndham Hotels & Resorts
WH
$5.46B
$1.61M 0.19%
28,935
+60
+0.2% +$3.28K
MDT icon
110
Medtronic
MDT
$107B
$1.61M 0.19%
16,492
-590
-3% -$53.9K
SNY icon
111
Sanofi
SNY
$104B
$1.57M 0.19%
36,294
+1,250
+4% +$53.2K
PNFP icon
112
Pinnacle Financial Partners Inc
PNFP
$15.5B
$1.52M 0.18%
26,407
-6,178
-19% -$348K
AEM icon
113
Agnico Eagle Mines
AEM
$72.6B
$1.51M 0.18%
29,530
-620
-2% -$27.1K
FAM
114
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$1.49M 0.18%
143,603
-228,375
-61% -$2.29M
PBA icon
115
Pembina Pipeline
PBA
$29.9B
$1.48M 0.18%
39,880
+670
+2% +$24.4K
MSGS icon
116
Madison Square Garden
MSGS
$9.54B
$1.47M 0.18%
7,373
-37
-0.5% -$7.88K
TCBIP
117
DELISTED
Texas Capital Bancshares, Inc. Non Cumulative Preferred Perpetual Stock Series A
TCBIP
$1.45M 0.18%
55,700
+1,200
+2% +$31.2K
RNR.PRF icon
118
RenaissanceRe Holdings 5.75% Series F Preference Share
RNR.PRF
$207M
$1.45M 0.17%
56,045
+5,500
+11% +$140K
BP icon
119
BP
BP
$113B
$1.43M 0.17%
34,980
PCEF icon
120
Invesco CEF Income Composite ETF
PCEF
$812M
$1.42M 0.17%
62,735
+2,975
+5% +$66.5K
PEP icon
121
PepsiCo
PEP
$186B
$1.41M 0.17%
10,749
QQQ icon
122
Invesco QQQ Trust
QQQ
$455B
$1.41M 0.17%
7,530
-510
-6% -$93.9K
PG icon
123
Procter & Gamble
PG
$343B
$1.36M 0.16%
12,420
CAT icon
124
Caterpillar
CAT
$409B
$1.36M 0.16%
9,967
+150
+2% +$19.8K
ALLY.PRA
125
DELISTED
GMAC Capital Trust I 8.125% Fixed Rate/Floating Rate Trust Preferred Securities, Series 2
ALLY.PRA
$1.34M 0.16%
51,310
-2,575
-5% -$67.6K

Similar funds

Oxbow Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Oxbow Advisors held 316 positions worth $830M, up 1% from $822M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Oxbow Advisors's Q2 2019 filing shows 20 new, 108 increased, 85 reduced and 10 closed positions. Its largest new stake was Plains GP Holdings: 280,562 shares worth $7.01M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $12.5M.

By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

  • Oxbow Advisors's largest Q2 2019 buy was Plains GP Holdings: 280,562 shares worth $7.01M.
  • Oxbow Advisors added most to iShares 20+ Year Treasury Bond ETF in Q2 2019, an estimated $5.48M increase.
  • Oxbow Advisors's biggest Q2 2019 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $12.5M.
  • Oxbow Advisors fully exited Goldcorp Inc in Q2 2019, selling an estimated $1.13M.
  • Oxbow Advisors's ten largest holdings make up 33% of its $830M portfolio in Q2 2019.
  • Oxbow Advisors opened 20 new positions and closed 10 in Q2 2019.
  • Oxbow Advisors's portfolio value rose 1% quarter-over-quarter to $830M.

Based on Oxbow Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.